We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Highly-integrated Lab-on-a-chip System for Multiparameter Analysis at the Point-of-care

Video   Jun 10, 2015

 

An innovative approach towards a marketable lab-on-a-chip system for in vitro diagnostics at the point-of-care is reported. A lab-on-a-chip system called the "Fraunhofer ivD-platform" has been established which opens up the possibility for an on-site analysis at low costs. The system features a high degree of modularity and integration. Modularity allows the adaption of common and established assay types of various formats. Integration lets the system move from the laboratory to the point-of-need. By making use of the microarray format the lab-on-a-chip system also addresses the trend of multiplex detection in biomedicine. The system consists of a credit-card sized cartridge (lab-on-a-chip) and a base-unit. A clinical sample, e.g. a drop of blood can be applied directly to the cartridge and will be analyzed automatically. All biochemical reagents, which are necessary for the assay, are already included in the cartridge. A proprietary pumping system enables an automated processing after insertion of the cartridge into the base-unit. After about 15 min, the results of the diagnostic analysis appear on a display and the physician can directly undertake therapeutic action. The open/flexible character of the ivD-platform, allows the integration of e.g. the following assay formats: - Immunological assays, automated ELISA (antibody - microarray)e.g. CRP-assay- Serological assays (protein / peptide - microarray)e.g. autoimmune-diagnostics- DNA diagnostics (DNA - microarray)e.g. species-identification + antibiotic resistance detection. Other assay formats are possible (e.g. using aptamers), but have not been tested so far. New or existing assays can easily be transferred onto the ivD-platform, which are then ready for mass production.

 
 
 
Advertisement
 

Recommended Videos

Giant Spider Provides Promise of Pain Relief for Irritable Bowel Syndrome

Video

Molecules from the venom of one of the world’s largest spiders could help researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

WATCH NOW

Teach Me in 10 – Engineering a Decoy Receptor for SARS-CoV-2 With Dr Erik Procko, Part II

Video

Dr Erik Procko has been working on engineering a "decoy" receptor for SARS-CoV-2, the virus that has caused the COVID-19 global pandemic. In the second video of this two-part installment, Dr Procko discusses his research in exploring the mutational landscape of ACE2 to further understand the interaction between the receptor and the S protein of SARS-CoV-2.

WATCH NOW

Bruker's Mass Spec Demo facility: Ensuring safe operation in COVID-19 and beyond

Video

This video showcases Bruker's Mass Spec Demo facility and how they are keeping employees safe and in operation during COVID-19 and beyond.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Diagnostics Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE